UKBizDB.co.uk

BLUESKY PHARMA LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Bluesky Pharma Limited. The company was founded 16 years ago and was given the registration number 06457134. The firm's registered office is in STANMORE. You can find them at 1st Floor Stanmore House, 15-19 Church Road, Stanmore, Middlesex. This company's SIC code is 70229 - Management consultancy activities other than financial management.

Company Information

Name:BLUESKY PHARMA LIMITED
Company Number:06457134
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:19 December 2007
End of financial year:30 April 2023
Jurisdiction:England - Wales
Industry Codes:
  • 70229 - Management consultancy activities other than financial management

Office Address & Contact

Registered Address:1st Floor Stanmore House, 15-19 Church Road, Stanmore, Middlesex, HA7 4AR
Country Origin:
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
C/O Cowen Suite, Kinetic Centre, Theobald Street, Borehamwood, England, WD6 4PJ

Secretary19 December 2007Active
C/O Cowen Suite, Kinetic Centre, Theobald Street, Borehamwood, England, WD6 4PJ

Director19 December 2007Active
26 Gurney Drive, London, N2 0DG

Director19 December 2007Active

People with Significant Control

Mr David Schemtob
Notified on:06 April 2016
Status:Active
Date of birth:March 1964
Nationality:British
Country of residence:England
Address:C/O Cowen Suite, Kinetic Centre, Borehamwood, England, WD6 4PJ
Nature of control:
  • Ownership of shares 75 to 100 percent

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (1 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (0 months remaining)

Copyright © 2024. All rights reserved.